000 | 01323 a2200361 4500 | ||
---|---|---|---|
005 | 20250517174617.0 | ||
264 | 0 | _c20180530 | |
008 | 201805s 0 0 eng d | ||
022 | _a2044-6055 | ||
024 | 7 |
_a10.1136/bmjopen-2016-015110 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLassman, Scott M | |
245 | 0 | 0 |
_aClinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States. _h[electronic resource] |
260 |
_bBMJ open _cSep 2017 |
||
300 |
_ae015110 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAccess to Information |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCross-Sectional Studies _xstatistics & numerical data |
650 | 0 | 4 |
_aDisclosure _xlegislation & jurisprudence |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRegistries _xstatistics & numerical data |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aShopshear, Olivia M | |
700 | 1 | _aJazic, Ina | |
700 | 1 | _aUlrich, Jocelyn | |
700 | 1 | _aFrancer, Jeffrey | |
773 | 0 |
_tBMJ open _gvol. 7 _gno. 9 _gp. e015110 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmjopen-2016-015110 _zAvailable from publisher's website |
999 |
_c27596682 _d27596682 |